DE69820065D1 - Gastrokinetische monocyclische benzamide von 3- oder 4-substituierte 4-(aminomethyl)-piperidinderivative - Google Patents

Gastrokinetische monocyclische benzamide von 3- oder 4-substituierte 4-(aminomethyl)-piperidinderivative

Info

Publication number
DE69820065D1
DE69820065D1 DE69820065T DE69820065T DE69820065D1 DE 69820065 D1 DE69820065 D1 DE 69820065D1 DE 69820065 T DE69820065 T DE 69820065T DE 69820065 T DE69820065 T DE 69820065T DE 69820065 D1 DE69820065 D1 DE 69820065D1
Authority
DE
Germany
Prior art keywords
gastrokinetic
aminomethyl
substituted
piperidine derivatives
benzamides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69820065T
Other languages
English (en)
Other versions
DE69820065T2 (de
Inventor
Jean-Paul Rene Marie A Bosmans
Michel Anna Jozef De Cleyn
Michel Surkyn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceutica NV
Original Assignee
Janssen Pharmaceutica NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica NV filed Critical Janssen Pharmaceutica NV
Publication of DE69820065D1 publication Critical patent/DE69820065D1/de
Application granted granted Critical
Publication of DE69820065T2 publication Critical patent/DE69820065T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/42—Oxygen atoms attached in position 3 or 5
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/06—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with radicals, containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/48—Oxygen atoms attached in position 4 having an acyclic carbon atom attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/12—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/14—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/14—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/16—Radicals substituted by halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
DE69820065T 1997-07-11 1998-07-07 Gastrokinetische monocyclische benzamide von 3- oder 4-substituierte 4-(aminomethyl)-piperidinderivative Expired - Lifetime DE69820065T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP97202180 1997-07-11
EP97202180 1997-07-11
EP98200624 1998-02-27
EP98200624 1998-02-27
PCT/EP1998/004189 WO1999002494A1 (en) 1997-07-11 1998-07-07 Gastrokinetic monocyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives

Publications (2)

Publication Number Publication Date
DE69820065D1 true DE69820065D1 (de) 2004-01-08
DE69820065T2 DE69820065T2 (de) 2004-08-26

Family

ID=26146699

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69820065T Expired - Lifetime DE69820065T2 (de) 1997-07-11 1998-07-07 Gastrokinetische monocyclische benzamide von 3- oder 4-substituierte 4-(aminomethyl)-piperidinderivative
DE69809050T Expired - Lifetime DE69809050T2 (de) 1997-07-11 1998-07-07 Gastrokinetische bicyclische benzamide von 3- oder 4-substituierten 4-(aminomethyl)-piperidinderivaten

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE69809050T Expired - Lifetime DE69809050T2 (de) 1997-07-11 1998-07-07 Gastrokinetische bicyclische benzamide von 3- oder 4-substituierten 4-(aminomethyl)-piperidinderivaten

Country Status (34)

Country Link
US (10) US6452013B1 (de)
EP (3) EP0991410B1 (de)
JP (2) JP4530530B2 (de)
KR (2) KR100885658B1 (de)
CN (2) CN1117568C (de)
AR (2) AR013361A1 (de)
AT (2) ATE226820T1 (de)
AU (2) AU747199B2 (de)
BG (2) BG64230B1 (de)
BR (2) BR9811687A (de)
CA (2) CA2295087C (de)
CZ (2) CZ297298B6 (de)
DE (2) DE69820065T2 (de)
DK (2) DK0991410T3 (de)
EA (1) EA002619B1 (de)
EE (1) EE04178B1 (de)
ES (2) ES2187051T3 (de)
HK (2) HK1025093A1 (de)
HR (2) HRP20000005B1 (de)
HU (2) HU227424B1 (de)
ID (2) ID24161A (de)
IL (2) IL133917A (de)
MY (2) MY123199A (de)
NO (2) NO314662B1 (de)
NZ (2) NZ502208A (de)
PL (2) PL190310B1 (de)
PT (2) PT991410E (de)
RU (1) RU2213089C2 (de)
SI (2) SI1000028T1 (de)
SK (2) SK284632B6 (de)
TR (2) TR200000023T2 (de)
TW (2) TW548103B (de)
UA (1) UA67745C2 (de)
WO (2) WO1999002494A1 (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW548103B (en) * 1997-07-11 2003-08-21 Janssen Pharmaceutica Nv Bicyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives
TW570920B (en) * 1998-12-22 2004-01-11 Janssen Pharmaceutica Nv 4-(aminomethyl)-piperidine benzamides for treating gastrointestinal disorders
US20040253179A1 (en) * 2003-02-26 2004-12-16 Acm Medical Technologies, Inc. Measuring gastrointestinal parameters
US20080219928A1 (en) * 2003-02-26 2008-09-11 Becker Jane A Measuring Gastrointestinal Parameters
WO2005003122A1 (en) * 2003-06-19 2005-01-13 Janssen Pharmaceutica N.V. 5ht4-antagonistic 4-(aminomethyl)-piperidine benzamides
ES2336448T3 (es) * 2003-06-19 2010-04-13 Janssen Pharmaceutica Nv 4-(aminometil)-piperidina-benzamidas con sustituyentes heterociclicos como antagonistas de 5ht4.
JO2478B1 (en) * 2003-06-19 2009-01-20 جانسين فارماسوتيكا ان. في. (Aminomethyl) -biperidine benzamides as 5 HT4 antagonists
AU2004251823B2 (en) * 2003-06-19 2010-06-03 Janssen Pharmaceutica N.V. Aminosulfonyl substituted 4-(aminomethyl)-piperidine benzamides as 5HT4-antagonists
ATE388146T1 (de) 2004-01-29 2008-03-15 Pfizer 1-isopropyl-2-oxo-1,2-dihydropyridin-3- carbonsäureamidderivate mit agonistischer wirkung am 5-ht4-rezeptor
TW200533348A (en) * 2004-02-18 2005-10-16 Theravance Inc Indazole-carboxamide compounds as 5-ht4 receptor agonists
WO2005092882A1 (en) * 2004-03-01 2005-10-06 Pfizer Japan, Inc. 4-amino-5-halogeno-benzamide derivatives as 5-ht4 receptor agonists for the treatment of gastrointestinal, cns, neurological and cardiovascular disorders
US7728006B2 (en) * 2004-04-07 2010-06-01 Theravance, Inc. Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
US8309575B2 (en) 2004-04-07 2012-11-13 Theravance, Inc. Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
TWI351282B (en) 2004-04-07 2011-11-01 Theravance Inc Quinolinone-carboxamide compounds as 5-ht4 recepto
DE602005016446D1 (de) * 2004-11-05 2009-10-15 Theravance Inc 5-HT4-Rezeptoragonistenverbindungen
ATE431824T1 (de) * 2004-11-05 2009-06-15 Theravance Inc Chinolinon-carboxamid-verbindungen
US20070020330A1 (en) 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
PT2522365T (pt) 2004-11-24 2017-02-08 Meda Pharmaceuticals Inc Composições que compreendem azelastina e seus métodos de utilização
ES2347265T3 (es) * 2004-12-22 2010-10-27 Theravance, Inc. Compuestos de indazol-carboxamida.
KR20070107807A (ko) * 2005-03-02 2007-11-07 세라밴스 인코포레이티드 5-ｈｔ4 수용체 아고니스트인 퀴놀리논 화합물
TWI377206B (en) * 2005-04-06 2012-11-21 Theravance Inc Crystalline form of a quinolinone-carboxamide compound
GB0603550D0 (en) * 2006-02-22 2006-04-05 Glaxo Group Ltd Novel compounds
US9654833B2 (en) 2007-06-26 2017-05-16 Broadband Itv, Inc. Dynamic adjustment of electronic program guide displays based on viewer preferences for minimizing navigation in VOD program selection
US8642772B2 (en) 2008-10-14 2014-02-04 Sk Biopharmaceuticals Co., Ltd. Piperidine compounds, pharmaceutical composition comprising the same and its use
US20110313319A1 (en) * 2008-11-07 2011-12-22 SAND COUNTY BIOTECHNOLOGY, Inc. Measuring method for the concentration of intragastric contents
US8232315B2 (en) 2009-06-26 2012-07-31 Sk Biopharmaceuticals Co., Ltd. Methods for treating drug addiction and improving addiction-related behavior
AU2010316106B2 (en) 2009-11-06 2015-10-22 Sk Biopharmaceuticals Co., Ltd. Methods for treating attention-deficit/hyperactivity disorder
MX350745B (es) 2009-11-06 2017-09-14 Sk Biopharmaceuticals Co Ltd * El uso de un compuesto de carbamoilo para el tratamiento del sindrome de fibromialgia.
KR101180174B1 (ko) * 2010-04-23 2012-09-05 동아제약주식회사 신규한 벤즈아미드 유도체
US9610274B2 (en) 2010-06-30 2017-04-04 Sk Biopharmaceuticals Co., Ltd. Methods for treating bipolar disorder
US8623913B2 (en) 2010-06-30 2014-01-07 Sk Biopharmaceuticals Co., Ltd. Methods for treating restless legs syndrome
JP6182989B2 (ja) 2012-06-28 2017-08-23 セントラル硝子株式会社 １，３，３，３−テトラフルオロプロペンの製造方法
WO2014083003A1 (en) 2012-11-27 2014-06-05 Shire International Gmbh Pro-cognitive compound
KR101595183B1 (ko) * 2013-07-25 2016-02-17 동아에스티 주식회사 벤즈아미드 유도체의 제조방법, 그의 제조에 사용되는 새로운 중간체 및 상기 중간체의 제조방법

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1046052B (it) * 1973-10-12 1980-06-30 Sigurta Farmaceutici Spa Processo per la preparazione di i aralchil 4 aminometil piperidin 4 oli
US4348763A (en) * 1980-08-07 1982-09-07 Hewlett-Packard Company Multiple stripe leaky mode laser
US4711703A (en) 1982-02-03 1987-12-08 Orbisphere Corporation Wilmington, Succursale De Collonge-Bellerive Thermal protection method for electroanalytical cell
DE3416224C2 (de) 1983-05-06 1994-05-05 Mitsubishi Chem Ind Verfahren zur Herstellung eines Kohleverflüssigungsöls
US4772630A (en) 1984-11-23 1988-09-20 Ciba-Geigy Corp. Benzamides and their salts
US4722630A (en) 1985-09-20 1988-02-02 The Garrett Corporation Ceramic-metal braze joint
GB8527052D0 (en) 1985-11-02 1985-12-04 Beecham Group Plc Compounds
US4910312A (en) 1985-11-08 1990-03-20 Warner-Lambert Company Various N-substituted 3-piperidine carboxylic acids or N-substituted 3-pyridinecarboxylic acids and derivatives thereof
US4910193A (en) 1985-12-16 1990-03-20 Sandoz Ltd. Treatment of gastrointestinal disorders
US4746655A (en) * 1987-06-10 1988-05-24 A. H. Robins Company, Incorporated Fused aromatic-spiropiperidine oxazepinones(and thiones)
BE1000689A6 (fr) 1987-07-14 1989-03-14 Donnay Donnay S A Ets Raquette de tennis, de squash ou sport analogue.
US5130312A (en) 1987-07-17 1992-07-14 Janssen Pharmaceutica N.V. Substituted N-(3-hydroxy-4-piperidinyl)benzamides
NZ225152A (en) 1987-07-17 1990-04-26 Janssen Pharmaceutica Nv Heterocyclically substituted piperidinyl benzamides as pharmaceuticals
US4906643A (en) 1987-07-17 1990-03-06 Janssen Pharmaceutica N.V. Substituted N-(3-hydroxy-4-piperidinyl)benzamides as gastrointestinal agents
JPH0719937B2 (ja) * 1987-09-24 1995-03-06 三井石油化学工業株式会社 高周波用積層板およびその製造方法
CA1317940C (en) 1987-09-25 1993-05-18 Georges H. P. Van Daele Substituted n-(1-alkyl-3-hydroxy-4-piperidinyl)benzamides
US4975439A (en) 1987-09-25 1990-12-04 Janssen Pharmaceutical N.V. Novel substituted N-(1-alkyl-3-hydroxy-4-piperidinyl)benzamides
US5041454A (en) 1987-09-25 1991-08-20 Janssen Pharmaceutica N.V. Novel substituted N-(1-alkyl-3-hydroxy-4-piperidinyl)benzamides
JP2573017B2 (ja) 1988-03-08 1997-01-16 三洋電機株式会社 ディスクプレーヤ
US5053412A (en) 1990-04-10 1991-10-01 Israel Institute For Biological Research Spiro nitrogen-bridged heterocyclic compounds
US5374637A (en) * 1989-03-22 1994-12-20 Janssen Pharmaceutica N.V. N-(3-hydroxy-4-piperidinyl)(dihydrobenzofuran, dihydro-2H-benzopyran or dihydrobenzodioxin)carboxamide derivatives
GB9005014D0 (en) 1990-03-06 1990-05-02 Janssen Pharmaceutica Nv N.(4.piperidinyl)(dihydrobenzofuran or dihydro.2h.benzopyran)carboxamide derivatives
US5103141A (en) 1990-03-08 1992-04-07 U.S. Philips Corporation Switching arrangement for increasing the white life of a high pressure sodium lamp
US5534520A (en) 1990-04-10 1996-07-09 Fisher; Abraham Spiro compounds containing five-membered rings
US5407938A (en) 1990-04-10 1995-04-18 Israel Institute For Biological Research Certain 1-methyl-piperidine-4-spiro-4'-(1'-3'-oxazolines) and corresponding -(1',3' thiazolines)
TW213460B (de) * 1991-02-15 1993-09-21 Hokuriku Pharmaceutical
JPH06510283A (ja) 1991-08-20 1994-11-17 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー ５−ｈｔ４レセプター拮抗薬
SG49153A1 (en) 1991-09-12 1998-05-18 Smithkline Beecham Plc 5-HT4 receptor antagonists
IT1252567B (it) * 1991-12-20 1995-06-19 Italfarmaco Spa Derivati di 5-isochinolinsolfonammidi inibitori delle protein-chinasi
WO1993013101A1 (en) * 1991-12-27 1993-07-08 Yoshitomi Pharmaceutical Industries, Ltd. Pyridonecarboxylate compound, pharmaceutical use thereof, and spiro compound
AU667874B2 (en) 1992-02-06 1996-04-18 Smithkline Beecham Plc Benzopyran, benzothiopyran and benzofuran derivatives as 5-HT4 antagonists
JPH05236345A (ja) 1992-02-21 1993-09-10 Nec Ic Microcomput Syst Ltd 画像用垂直フィルタ回路
MX9306311A (es) 1992-10-13 1994-04-29 Smithkline Beecham Plc Compuestos antagonistas del receptor de 5-ht4, procedimiento para su preparacion y composiciones farmaceuticas que los contienen
AU680453B2 (en) 1992-11-05 1997-07-31 Smithkline Beecham Plc Piperidine derivatives as 5-HT4 receptor antagonists
US6127379A (en) * 1993-02-01 2000-10-03 Smithkline Beecham P.L.C. Benzopyran, benzothiopyran and benzofuran derivatives as 5-HT4 antagonists
WO1995026953A1 (fr) * 1994-03-30 1995-10-12 Yoshitomi Pharmaceutical Industries, Ltd. Compose d'acide benzoïque et son utilisation comme medicament
US5864039A (en) * 1994-03-30 1999-01-26 Yoshitomi Pharmaceutical Industries, Ltd. Benzoic acid compounds and use thereof as medicaments
TW490465B (en) * 1994-11-24 2002-06-11 Janssen Pharmaceutica Nv Enterokinetic benzamide, the preparation process and the pharmaceutical compositions thereof
GB9507882D0 (en) * 1995-04-18 1995-05-31 Pharmacia Spa Substituted dihydrobenzofuran derivatives as 5-ht4 agonists
EP0873990A1 (de) * 1995-09-22 1998-10-28 Yoshitomi Pharmaceutical Industries, Ltd. Benzoesäureverbindungen und ihre medizinische anwendung
US6096761A (en) * 1996-02-15 2000-08-01 Janssen Pharmaceutica N.V. Esters of 3-hydroxy-piperidinemethanol derivatives
KR100469029B1 (ko) * 1996-02-15 2005-05-27 얀센 파마슈티카 엔.브이. 세로토닌재흡수억제제의위장효과를극복하기위한5ht4수용체길항제의용도
TW548103B (en) 1997-07-11 2003-08-21 Janssen Pharmaceutica Nv Bicyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives
EP0950243A1 (de) 1997-10-31 1999-10-20 Deawoo Electronics Co., Ltd. Compactdiskwechsler mit durch eine einzige antriebsquelle angetriebenem antriebsmechanismus
EP1112270B1 (de) * 1998-09-10 2007-03-21 F. Hoffmann-La Roche Ag Dihydrobenzodioxincarbonsäureamid- und ketonderivate als 5-ht4-rezeptorantagonisten

Also Published As

Publication number Publication date
HRP20000005A2 (en) 2000-12-31
DE69809050D1 (de) 2002-12-05
BRPI9811688B8 (pt) 2021-07-06
AR016324A1 (es) 2001-07-04
BR9811687A (pt) 2000-09-26
EP1206938A1 (de) 2002-05-22
BG64230B1 (bg) 2004-06-30
SK284942B6 (sk) 2006-02-02
HUP0004564A3 (en) 2001-08-28
EE200000015A (et) 2000-10-16
AU734475B2 (en) 2001-06-14
BRPI9811688B1 (pt) 2011-10-18
NO317467B1 (no) 2004-11-01
UA67745C2 (uk) 2004-07-15
NZ502208A (en) 2001-04-27
CZ463899A3 (cs) 2000-04-12
BG63709B1 (bg) 2002-10-31
CA2295087A1 (en) 1999-01-21
PL190310B1 (pl) 2005-11-30
NO20000115L (no) 2000-03-13
ATE226820T1 (de) 2002-11-15
EA002619B1 (ru) 2002-06-27
KR20010014341A (ko) 2001-02-26
US20060142342A1 (en) 2006-06-29
MY117803A (en) 2004-08-30
CN1262621A (zh) 2000-08-09
US6635643B2 (en) 2003-10-21
DK0991410T3 (da) 2003-02-24
AU747199B2 (en) 2002-05-09
AR013361A1 (es) 2000-12-27
ID24481A (id) 2000-07-20
IL133918A (en) 2004-06-20
ID24161A (id) 2000-07-13
EE04178B1 (et) 2003-12-15
SK173499A3 (en) 2000-06-12
SK284632B6 (sk) 2005-08-04
ES2187051T3 (es) 2003-05-16
KR100500372B1 (ko) 2005-07-11
NO20000115D0 (no) 2000-01-10
CN1117568C (zh) 2003-08-13
CA2295088C (en) 2007-10-23
RU2213089C2 (ru) 2003-09-27
JP4530530B2 (ja) 2010-08-25
CZ297298B6 (cs) 2006-11-15
US8063070B2 (en) 2011-11-22
CA2295087C (en) 2007-05-15
EP1000028A1 (de) 2000-05-17
JP2001509503A (ja) 2001-07-24
BG103984A (en) 2000-09-29
US20100210657A1 (en) 2010-08-19
NO20000116D0 (no) 2000-01-10
EP0991410B1 (de) 2002-10-30
PL338008A1 (en) 2000-09-25
EP0991410A1 (de) 2000-04-12
SI0991410T1 (en) 2003-04-30
PL338005A1 (en) 2000-09-25
WO1999002156A1 (en) 1999-01-21
IL133918A0 (en) 2001-04-30
TW548103B (en) 2003-08-21
NZ502209A (en) 2001-01-26
US20020086879A1 (en) 2002-07-04
TR200000023T2 (tr) 2000-09-21
US8318742B2 (en) 2012-11-27
TR200000022T2 (tr) 2000-06-21
SI1000028T1 (en) 2004-04-30
CZ458799A3 (cs) 2000-05-17
EP1000028B1 (de) 2003-11-26
HUP0002539A3 (en) 2002-03-28
NO20000116L (no) 2000-03-07
BRPI9811688A (pt) 2000-09-26
AU8806398A (en) 1999-02-08
US7790750B2 (en) 2010-09-07
HRP20000006B1 (en) 2009-06-30
DE69809050T2 (de) 2003-07-24
CN1195736C (zh) 2005-04-06
NO314662B1 (no) 2003-04-28
US6452013B1 (en) 2002-09-17
US6750349B2 (en) 2004-06-15
US20060142341A1 (en) 2006-06-29
CZ295506B6 (cs) 2005-08-17
KR100885658B1 (ko) 2009-02-25
BG103983A (en) 2000-09-29
AU8857498A (en) 1999-02-08
US20070037850A1 (en) 2007-02-15
SK184099A3 (en) 2000-09-12
PL190611B1 (pl) 2005-12-30
CA2295088A1 (en) 1999-01-21
DK1000028T3 (da) 2004-04-05
HK1025047A1 (en) 2000-11-03
MY123199A (en) 2006-05-31
ES2212330T3 (es) 2004-07-16
HRP20000006A2 (en) 2000-12-31
PT1000028E (pt) 2004-04-30
JP2002508000A (ja) 2002-03-12
HU227424B1 (en) 2011-05-30
IL133917A (en) 2005-05-17
US20040058958A1 (en) 2004-03-25
EA200000110A1 (ru) 2000-08-28
ATE255092T1 (de) 2003-12-15
USRE40793E1 (en) 2009-06-23
HUP0002539A2 (hu) 2000-12-28
KR20010014336A (ko) 2001-02-26
HK1025093A1 (en) 2000-11-03
TW402591B (en) 2000-08-21
IL133917A0 (en) 2001-04-30
WO1999002494A1 (en) 1999-01-21
HRP20000005B1 (en) 2008-12-31
US20030078427A1 (en) 2003-04-24
US20120028987A1 (en) 2012-02-02
CN1262674A (zh) 2000-08-09
PT991410E (pt) 2003-03-31
DE69820065T2 (de) 2004-08-26
HUP0004564A2 (hu) 2001-07-30

Similar Documents

Publication Publication Date Title
DE69820065D1 (de) Gastrokinetische monocyclische benzamide von 3- oder 4-substituierte 4-(aminomethyl)-piperidinderivative
EE9900053A (et) 4-(5-metüül-3-fenüülisoksasool-4-üül)benseensulfoonamiidi kristalliline vorm
DE60041145D1 (de) Nutzung von daten
DE59912795D1 (de) Substituierte Benzamide und ihre Verwendung als Immunmodulatoren
PT1140915E (pt) 4-(aminometil)-piperidina benzamidas para o tratamento de perturbacoes gastrointestinais
DE69801878D1 (de) Verwendung von Oxamatderivaten als Depigmentierungsmittel
EE200200462A (et) Piperidiini ja piperasiiniga asendatud N-hüdroksüformamiidid kui metalloproteinaaside inhibiitorid
ATE243197T1 (de) Kristallformen von osanetant
DE69834262D1 (de) Neue pharnazeutische verwendung von c-c chemokin produktionsinhibitoren
ATE298333T1 (de) Synthese von 4-(piperidyl) (2-pyridyl)methanon- (e)-o-methyloxim und seinen salzen
ZA986167B (en) Monocyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives.
ATE525362T1 (de) 2-(3-(4-(2-t-butyl-6-trifluormethylpyrimidin-4-
SI1436282T1 (en) Synthesis of 4-(piperidyl) (2-pyridyl)methanone-(e)-o-methyloxime and its salts
AU2002359274A1 (en) Synthesis of 4-(piperidyl) (2-pyridyl)methanone-(e)-o-methyloxime and its salts
DK0848707T3 (da) Derivater af 4-(cycloalkyl)piperidiner og 4-(cycloalkyl)piperidiner, deres fremstilling og terapeutiske anvendelse
IT231023Y1 (it) Chiodo a doppia testa particolarmente idoneo nelle casserature edilizie

Legal Events

Date Code Title Description
8364 No opposition during term of opposition